Clinical Trial

To Evaluate the Efficacy and Safety of 'BRDE33-100' for the Temporary Correction of Moderate to Severe Nasolabial Folds

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to demonstrate the non-inferiority of BRDE33-100 to Soonsoofill in temporarily improving moderate to severe nasolabial folds.
Trial Details
NCT Number NCT07069920
Lead Sponsor BRPharm Co., Ltd.
Conditions Nasolabial Folds
Enrollment 128 participants
Start Date 2024-11-14
Primary Completion 2025-06-25 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-07-17